Nobody rings it at the top nor does anyone ring it at the bottom! You wouldn't think we had major results due in the very short term but we have and imo you couldn't ask for a better short term opportunity anywhere in Aust mini biotech land. 1103 final results due June 1102 final results due June Stem cell mobilisation results due June Update on Scm should be due soon on trial completion imo. Update on 1103 additional dosing due soon imo. Wildcard would be partnering interest and or due diligence on 1102 and 1103 that will come out of the blue around this period or before imo. Hard to believe we are tracking at the same levels of 3 years ago with a 20 mill mc with all the company has achieved since then and the close proximity of all 3 major inflection points. Unbelievable value but I suppose everyone waits until it hits 18,19, 20 to buy. Kind of ironic really - the best opportunities at the bottom and top are too often ignored.
ANP Price at posting:
15.0¢ Sentiment: LT Buy Disclosure: Held
